Dexmedetomidine post-conditioning alleviates myocardial ischemia–reperfusion injury in rats by ferroptosis inhibition via SLC7A11/GPX4 axis activation

[1]  D. Pei,et al.  System Xc−: a key regulatory target of ferroptosis in cancer , 2021, Investigational New Drugs.

[2]  Zhilin Wu,et al.  Dexmedetomidine Protects against Myocardial Ischemia/Reperfusion Injury by Ameliorating Oxidative Stress and Cell Apoptosis through the Trx1-Dependent Akt Pathway , 2020, BioMed research international.

[3]  Jinqiao Qian,et al.  Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  Shu-guang Zhu,et al.  Galangin attenuated cerebral ischemia-reperfusion injury by inhibition of ferroptosis through activating the SLC7A11/GPX4 axis in gerbils. , 2020, Life sciences.

[5]  Chen Liu,et al.  Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury. , 2020, Free radical biology & medicine.

[6]  D. Klionsky,et al.  Ferroptosis: machinery and regulation , 2020, Autophagy.

[7]  Yong-qiang Yin,et al.  Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats. , 2020, International immunopharmacology.

[8]  Yangyang Xia,et al.  Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1 , 2020, Aging.

[9]  Juntian Liu,et al.  Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  Yalan Li,et al.  Dexmedetomidine alleviated sepsis-induced myocardial ferroptosis and septic heart injury , 2020, Molecular medicine reports.

[11]  Dan Han,et al.  Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis , 2020, Circulation research.

[12]  E. Li,et al.  Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cells. , 2020, Experimental and molecular pathology.

[13]  N. Chattipakorn,et al.  The effects of iron overload on mitochondrial function, mitochondrial dynamics, and ferroptosis in cardiomyocytes. , 2019, Archives of biochemistry and biophysics.

[14]  Lingqin Qiu,et al.  Dexmedetomidine protects SK-N-SH nerve cells from oxidative injury by maintaining iron homeostasis. , 2019, Biological & pharmaceutical bulletin.

[15]  Y. Leng,et al.  Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress. , 2019, DNA and cell biology.

[16]  Z. Xia,et al.  Dexmedetomidine post‐treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF‐1α signalling , 2019, Journal of cellular and molecular medicine.

[17]  Lina Lin,et al.  Dexmedetomidine protects against lung injury induced by limb ischemia‐reperfusion via the TLR4/MyD88/NF‐κB pathway , 2019, The Kaohsiung journal of medical sciences.

[18]  Hongliang Dong,et al.  Lipid Peroxidation and GPX4 Inhibition Are Common Causes for Myofibroblast Differentiation and Ferroptosis. , 2019, DNA and cell biology.

[19]  W. Gu,et al.  The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11. , 2019, Cancer research.

[20]  G. Sweeney,et al.  Iron induces insulin resistance in cardiomyocytes via regulation of oxidative stress , 2019, Scientific Reports.

[21]  F. Gao,et al.  Ferroptosis as a target for protection against cardiomyopathy , 2019, Proceedings of the National Academy of Sciences.

[22]  Minghui Gao,et al.  Role of Mitochondria in Ferroptosis. , 2019, Molecular cell.

[23]  J. Licht,et al.  Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia–reperfusion injury , 2019, Basic Research in Cardiology.

[24]  D. Klionsky,et al.  AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System Xc – Activity , 2018, Current Biology.

[25]  Minghui Gao,et al.  To eat or not to eat-the metabolic flavor of ferroptosis. , 2018, Current opinion in cell biology.

[26]  T. Matsui,et al.  Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes. , 2018, American journal of physiology. Heart and circulatory physiology.

[27]  Mingyan Zhao,et al.  Dexmedetomidine alleviates LPS-induced septic cardiomyopathy via the cholinergic anti-inflammatory pathway in mice. , 2017, American journal of translational research.

[28]  J. Yu,et al.  Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells1 , 2017, Neoplasia.

[29]  B. Stockwell,et al.  Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.

[30]  S. Mahboobi.  Dexmedetomidine and Renal Protection after Cardiac Surgery. , 2017, Journal of clinical anesthesia.

[31]  H. Imai,et al.  Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis. , 2017, Current topics in microbiology and immunology.

[32]  A. Walch,et al.  ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. , 2017, Nature chemical biology.

[33]  Yiheng Wang,et al.  Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway , 2016, International journal of molecular sciences.

[34]  D. Tang,et al.  Ferroptosis: process and function , 2016, Cell Death and Differentiation.

[35]  Minghui Gao,et al.  Glutaminolysis and Transferrin Regulate Ferroptosis. , 2015, Molecular cell.

[36]  G. Keating.  Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting , 2015, Drugs.

[37]  J. Gopas,et al.  Antioxidants and human diseases. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[38]  K. Sumikawa,et al.  Direct Protective Effects of Dexmedetomidine Against Myocardial Ischemia-Reperfusion Injury in Anesthetized Pigs , 2012, Shock.

[39]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[40]  G. Echevarría,et al.  Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart. , 2012, Biochimica et biophysica acta.

[41]  Hideyo Sato,et al.  The oxidative stress-inducible cystine/glutamate antiporter, system xc−: cystine supplier and beyond , 2011, Amino Acids.

[42]  R. Gaspari,et al.  Dexmedetomidine use in general anaesthesia. , 2009, Current drug targets.

[43]  A. Zangrillo,et al.  Halogenated anaesthetics and cardiac protection in cardiac and non-cardiac anaesthesia. , 2009, Annals of cardiac anaesthesia.

[44]  Robin A. J. Smith,et al.  Targeting an antioxidant to mitochondria decreases cardiac ischemia‐reperfusion injury , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  Y. Takemoto,et al.  Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats , 2004, Critical care medicine.

[46]  M. Singer,et al.  Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit , 1999, Anaesthesia.